Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Athersys (ATHX +6.4%) gets a boost today, possibly from an upbeat Seeking Alpha piece that touts...

  • Tuesday, January 22, 3:40 PM ET
    Athersys (ATHX +6.4%) gets a boost today, possibly from an upbeat Seeking Alpha piece that touts its strong pipeline. ATHX is a clinical stage biopharmaceutical company with a number of potential catalysts in its portfolio. Its most advanced programs are in the area of regenerative medicine using its stem cell therapy called MultiStem for the treatment of ischemic stroke. StemCells (STEM -2.3%) slips, possibly on the same article, which says it's in pre-clinical trials for the same indication, but its product isn't as advanced as that of ATHX.
Track new comments on this story

This news story has 1 comment:

  •  
    Suspect ATHX is a gem that has everything in place except the savvy PR required to inform the street of its potential. Perhaps a favorable article after months of silence woke a few investors up. Good to see.
    22 Jan, 04:23 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »